The ASX staged an info-tech fuelled recovery in the final hour, clawing back to neutral levels as losses in banking stocks ...

Cobre (ASX:CBE) secures a $4 million investment from Tribeca to support well-field development and exploration at the Ngami ...

Genetics Signatures says US sales of the company's Easyscreen diagnostics have disappointed, but a revamped strategy should ...

The ASX edged lower at lunch as oil rose on Black Sea strikes, miners slid and IperionX copped a sharp post-short seller ...

Tylah Tully looks at Vertex Minerals and the increasingly alluring gold grades coming out of its Reward gold mine in New ...

Zuleika reaches $48m settlement with Catalyst Metals and subsidiaries in long-running dispute over the Plutonic gold mine.

Adisyn (ASX:AI1) has passed another technical milestone, completing the initial phase of its low-temperature graphene ...

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Backed by government and industry partners, Micro-X is pushing its cold-cathode X-ray tech toward commercial readiness.

Salary sacrificing promises instant tax savings and a bigger nest egg, but it seems to have lost its lustre. Here’s why.

Rare earths and mineral sands hopeful Ark Mines wants to ride a wave of government support to production as soon as 2027.

Copper comes at a premium, and Garimpeiro likes the upside in one of the largest deposits owned by a junior developer.